greeksoup/ stock research
Stock research / United States / DNLI / Planned sales

Denali Therapeutics Inc. planned insider sales

In the last twelve months insiders at Denali Therapeutics Inc. filed 11 Form 144 notices of planned sales, 429,724 shares worth $8.9 million at the time of filing, from 7 sellers. The latest, filed 4 September 2026: Chin Peter Scott (officer), 1,654 shares worth $36,867, planned for around 4 September 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
4 September 2026Chin Peter ScottOfficer1,654$36,8674 September 20261,654 shares from 4 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock Lapse - See RemarksForm 144
2 September 2026Nancy ThornberryDirector11,439$266,1282 September 202611,439 shares from 2 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
1 September 2026Alexander SchuthOfficer2,768$65,7681 September 20262,768 shares from 1 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
11 August 2026Schuth Alexander O.Officer2,857$71,62411 August 20262,857 shares from 11 August 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock Lapse - See RemarksForm 144
5 February 2026Carole HoFormer Affiliate39,490$801,3945 February 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesExercise of options under a registered planForm 144
4 February 2026Carole HoFormer Affiliate150,000$3.2 million4 February 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesExercise of options under a registered planForm 144
3 February 2026Carole HoFormer Affiliate150,000$3.3 million3 February 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesExercise of options under a registered planForm 144
6 January 2026Ho CaroleConsultant17,218$284,0976 January 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock Lapse - See RemarksForm 144
6 January 2026Schuth Alexander O.Officer17,218$284,0976 January 202617,218 shares from 6 January 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock Lapse - See RemarksForm 144
6 January 2026Watts Ryan J.Director, Officer35,198$580,7676 January 202635,198 shares from 6 January 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock Lapse - See RemarksForm 144
4 December 2025Carole HoOfficer1,882$35,7584 December 2025No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?